<DOC>
	<DOCNO>NCT01819051</DOCNO>
	<brief_summary>The purpose study evaluate safety treat human toenail atmospheric plasma ( MOE Antimicrobial Plasma Treatment System ) get initial evaluation efficacy treatment toenail fungus ( onychomycosis ) .</brief_summary>
	<brief_title>Pilot Study Evaluate Plasma Treatment Onychomycosis</brief_title>
	<detailed_description />
	<mesh_term>Onychomycosis</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>Subject must 18 75 year age inclusive , either sex , race ; Subject must distal subungual infection affect approximately 25 % 50 % least one great toenail , clinically mycologically diagnose ; Subject must least 2 mm proximal end target toenail free infection ; Subject must target toenail assess capable grow approximately 1 mm/month , ( e.g. , subject need report cut toenail least per month ) ; Subject must willing give write informed consent able adhere procedure visit schedule ; Woman childbearing potential currently sexually active must agree use medically accept method contraception receive protocolspecified medication 30 day stop medication . Methods include condom ( male female ) without spermicidal agent , diaphragm cervical cap spermicide , medically prescribe intrauterine device , oral systemic hormonal contraceptive ( plus additional reliable barrier method ) , surgical sterilization ( e.g. , hysterectomy tubal ligation ) . Woman childbearing potential currently sexually active must agree use medically accept method contraception become sexually active participate study . Woman childbearing potential must negative serum pregnancy test within 72 hour prior start study drug . Subject one follow condition target toenail : proximal subungual onychomycosis , white superficial onychomycosis , dermatophytoma `` yellow spike/streak '' , exclusively lateral disease , inability become normal opinion investigator . Subject psoriasis , severe moccasintype tinea pedis require treatment , symptomatic interdigital tinea pedis , lichen planus , abnormality could result clinically abnormal nail ; Subject peripheral vascular disease peripheral circulatory impairment ; Subject history uncontrolled diabetes mellitus ; Subject know chronic active liver disease ; Subject known immunodeficiency ; Any pacemaker , metallic implant prostheses vicinity treatment site ( ankle , foot , etc. ) . Subject clinically significant condition situation , condition study , opinion investigator , would interfere study evaluation optimal participation study ; Subject receive systemic antifungal therapy within 6 month topical antifungal therapy apply foot toenail within 1 month study entry ; Subject receive radiation therapy , chemotherapy , and/or immunosuppressive drug within 6 month study , and/or oral corticosteroid &gt; 1 month within 6 month study ( exception : inhaled steroid ) ; Subject know received treatment investigational drug within 30 day prior enrollment study ; Subject unable communicate cooperate investigator due language problem , poor mental development , impaired cerebral function Subjects may unreliable study include subject engage excessive alcohol intake drug abuse ( test require ) , subject unable return schedule followup visit Woman breastfeeding , pregnant , intend become pregnant ; Subject part staff personnel directly involve study ; Subject family member investigational study staff .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>